,5 Pten counteracts the Pi3k/Akt/mechanistic target of rapamycin (mTOR) growth–promoting signaling cascade, a key proto-oncogenic player in cancer development and progression as well as a regulator of various cellular processes, including metabolism, survival, proliferation, apoptosis, growth, and cell migration.6 This evidence concerns the gene PTEN and cancer.